Quintet Private Bank (Europe)’s Day One Biopharmaceuticals DAWN Stock Holding History

Quintet Private Bank (Europe)’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,313	Closed	-$21.5K	–	203
2025 Q2	$21.5K	Hold	3,313	–	–	﹤0.01%	165
2025 Q1	$26.3K	Hold	3,313	–	–	﹤0.01%	155
2024 Q4	$42K	Hold	3,313	–	–	﹤0.01%	159
2024 Q3	$46.1K	Buy	3,313 +390	+13%	+$5.56K	﹤0.01%	151
2024 Q2	$45.7K	Buy	2,923 +4	+0.1%	+$59	﹤0.01%	157
2024 Q1	$54.4K	Sell	2,919 -394	-12%	-$5.9K	﹤0.01%	176
2023 Q4	$48.4K	Buy	3,313 +1,000	+43%	+$12.1K	﹤0.01%	152
2023 Q3	$28.4K	Buy	2,313 +11	+0.5%	+$143	﹤0.01%	179
2023 Q2	$27.5K	Sell	2,302 -13	-0.6%	-$170	﹤0.01%	205
2023 Q1	$31K	Buy	+2,315	New	+$45.2K	﹤0.01%	207
2022 Q2	$27.5K	Buy	+2,302	New	+$23.8K	﹤0.01%	205

Other funds holding DAWN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Quintet Private Bank (Europe)'s DAWN Position: Q3 2025 in Review

Quintet Private Bank (Europe) sold out of Day One Biopharmaceuticals (DAWN) in Q3 2025, closing a stake of 3,313 shares — an estimated $21.5K sold.

Quintet Private Bank (Europe) first reported a position in DAWN in Q2 2022 and held it in 11 quarters. The position peaked at $54.4K in Q1 2024. 172 funds tracked by Wall St. Rank hold DAWN as of Q3 2025.

Quintet Private Bank (Europe) reported no remaining Day One Biopharmaceuticals position as of Q3 2025 after selling out during the quarter.
Quintet Private Bank (Europe) sold 3,313 Day One Biopharmaceuticals shares in Q3 2025, an estimated $21.5K.
Quintet Private Bank (Europe) first reported a position in Day One Biopharmaceuticals in Q2 2022 and held it in 11 quarters.
Quintet Private Bank (Europe)'s Day One Biopharmaceuticals position peaked at $54.4K in Q1 2024.
172 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2025.

Based on Quintet Private Bank (Europe)'s 13F filing for Q3 2025, filed 7 Oct 2025.